The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BLACK STONE MINERALS | Common | 09225M101 | 52,458 | 4,879,824 | SH | SOLE | 4,879,824 | 0 | 0 | ||
| UNITY BIOTECHNOLOGY INC | Common | 91381U101 | 7,294 | 1,571,981 | SH | SOLE | 1,571,981 | 0 | 0 | ||
| EVELO BIOSCIENCES INC | Common | 299734103 | 6,585 | 479,242 | SH | SOLE | 479,242 | 0 | 0 | ||
| Clearpoint Neuro Inc | Common | 18507C103 | 728 | 38,114 | SH | SOLE | 38,114 | 0 | 0 | ||
| BIOSIG TECH INC | Common | 09073N201 | 389 | 100,891 | SH | SOLE | 100,891 | 0 | 0 | ||
| Zentalis Pharmaceuticals Inc | Common | 98943L107 | 18,751 | 352,459 | SH | SOLE | 352,459 | 0 | 0 | ||
| Sorento Therapeutics | Common | 83587F202 | 2,907 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| Teladoc Health Inc Com | Common | 87918A105 | 110 | 659 | SH | SOLE | 659 | 0 | 0 | ||
| Neuroon Medical Technologies | Common | 64130M209 | 1,205 | 181,754 | SH | SOLE | 181,754 | 0 | 0 | ||